Zobrazeno 1 - 10
of 1 094
pro vyhledávání: '"Allo hsct"'
Autor:
Cheng Zhang, Xiaoqi Wang, Hai Yi, Yi Wang, Zhiling Yan, Jian Zhou, Ting Yang, Aibin Liang, Zhen Wang, Yingying Ma, Qin Wen, Lei Gao, Li Gao, Peiyan Kong, Xu Tan, Erlie Jiang, Xi Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-4 (2024)
Abstract Chimeric Antigen Receptor T (CAR-T) cell therapy has significantly advanced in treating B-cell acute lymphoblastic leukemia (B-ALL) and has shown efficacy in managing relapsed B-ALL after allogeneic hematopoietic stem cell transplantation (a
Externí odkaz:
https://doaj.org/article/b6df4d5250e9414d96aecce10cbf0346
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 359-362 (2024)
Jing Liu, Ping Yang, Meng Hu Department of Hematology, First Affiliated Hospital of Henan University of Science and Technology, Henan, 471000, People’s Republic of ChinaCorrespondence: Meng Hu, Department of Hematology, First Affiliated Hospital of
Externí odkaz:
https://doaj.org/article/a602d00223d84720b3ffe5b67c994883
Autor:
Jing Ni, Jian Hong, Xinglin Liang, Jifei Dai, Zhangbiao Long, ChengXin Luan, Mingzhen Yang, Qingsheng Li
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102578- (2024)
Background: Thrombocytopenia after allogeneic hematopoietic cell transplantation is a challenging clinical problem. Recombinant human thrombopoietin (rhTPO) and thrombopoietin receptor agonists are increasingly used in posttransplant thrombocytopenia
Externí odkaz:
https://doaj.org/article/5087904f3c7b4959a969cd73617c7de9
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
This is the first report of NUP98::LEDGF positive malignant hematological tumor expressing T cell and myeloid lineage antigens. Patients carrying this fusion gene have a high relapse rate and a poor prognosis, allo-HSCT may be an option to cure this
Externí odkaz:
https://doaj.org/article/1230b9df22e84f24b9f0ad3a04f3281e
Autor:
Weihao Chen, Jingtao Huang, Yeqian Zhao, Luo Huang, Zhiyang Yuan, Miner Gu, Xiaojun Xu, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Chenhui Bao, Xin Huang, Zhongzheng Zheng, He Huang, Xiaoxia Hu, Yanmin Zhao
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Droplet digital PCR (ddPCR) is widely applied to monitor measurable residual disease (MRD). However, there are limited studies on the feasibility of ddPCR-MRD monitoring after allogeneic hematopoietic stem cell transplantation (al
Externí odkaz:
https://doaj.org/article/b5e9176f009c456f93505e9bee0b7ed9
Autor:
Xun-Hong Cao, Ze-Ying Fan, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Xiang-Yu Zhao
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Aims Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for hematological malignancies. However, viral infections, particularly EBV infection, frequently occur following allo-HSCT and can result in multi
Externí odkaz:
https://doaj.org/article/f73d003c82c44126b2450f7585b88c20
Autor:
Ming Ni, Jing Cui, Xin Yang, Yuntian Ding, Peng Zhao, Tianzhen Hu, Yun Zhan, Qian Kang, Xiuying Hu, Jiangyuan Zhao, Yao Xu, Lu Chen, Min Liu, Mei Zhao, Fengqi Zhang, Shisi Huang, Ya Li, Xueying Yang, Luxin Zhang, Tianzhuo Zhang, Bo Deng, Bing Yang, Deqin Lu, Jishi Wang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionGranulocytic myeloid-derived suppressor cells (G-MDSCs) show fast recovery following allogeneic hematopoietic stem cell transplantation (allo-HSCT) constituting the major part of peripheral blood in the early phase. Although G-MDSCs media
Externí odkaz:
https://doaj.org/article/2d56aec18a4a41d7828192e38723290a
Autor:
Zhihui Li, Lei Wang, Qinlong Zheng, Teng Xu, Keyan Yang, Xianxuan Wang, Xiaopei Wen, Caiyan Zhang, Jingjing Wang, Yanzhi Song, Yongqiang Zhao, Xiaoyu Zheng, Tong Wu
Publikováno v:
Cancer Reports, Vol 7, Iss 6, Pp n/a-n/a (2024)
Abstract Background In December 2022, a large‐scale epidemic occurred in China due to Omicron variant of SARS‐CoV‐2. This study explored risk factors for Omicron infection in transplant recipients at our institution and investigated the factors
Externí odkaz:
https://doaj.org/article/194abea39ddc4d65b5c91b75a94292bf
Autor:
B. Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, Andrea Lenartova, Mats Remberger, Ingerid Weum Abrahamsen, Geir Erland Tjønnfjord, Anders Eivind Myhre, Yngvar Fløisand, Tobias Gedde‐Dahl
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 117-124 (2024)
Abstract Outcomes of 2‐year survivours undergoing allo‐haematopoietic stem cell transplantation at Oslo University Hospital were retrospectively assessed with the objectives of identification of risk factors for late death as possible means for p
Externí odkaz:
https://doaj.org/article/6f59336744bb49a58d2ca6f2b8867c5f
Autor:
Xing-yu Cao, Jia-qi Chen, Hui Wang, Wei Ma, Wei-wei Liu, Fang-fang Zhang, Song Xue, Lei Dong, Ting Liu, Xiao-zhen Zhao, Chan-chan Liu, Xin Xu, Yang He, Lei Wang, Jian-ling Wang
Publikováno v:
Annals of Medicine, Vol 55, Iss 1, Pp 388-400 (2023)
AbstractBackground Venetoclax monotherapy is an effective option for patients with acute myeloid leukemia (AML). Venetoclax has also been used in non-myeloablative conditioning allogeneic hematopoietic stem cell transplantation (allo-HSCT) for high-r
Externí odkaz:
https://doaj.org/article/a3a0c37f50f84a2584cf1ea8f33e943a